// Sample data structure matching the expected format
export interface EligibilityTerm {
  term: string;
  disorder?: string;
  cancerType?: string;
  category: string;
  trialPercentage: string;
  inclusionExclusion: "Inclusion" | "Exclusion";
  fhirResource: string;
  standardCode: string;
  unstructured: string;
}

export const neurologyData: EligibilityTerm[] = [
  {
    term: "Age 18-85 years",
    disorder: "Alzheimer's Disease",
    category: "Demographics",
    trialPercentage: "95%",
    inclusionExclusion: "Inclusion",
    fhirResource: "Patient",
    standardCode: "LOINC:21112-8",
    unstructured: "Patient is 72 years old",
  },
  {
    term: "MMSE score 10-26",
    disorder: "Alzheimer's Disease",
    category: "Clinical",
    trialPercentage: "88%",
    inclusionExclusion: "Inclusion",
    fhirResource: "Observation",
    standardCode: "LOINC:72133-2",
    unstructured: "Mini-Mental State Exam score: 18/30",
  },
  {
    term: "CDR score 0.5-2.0",
    disorder: "Alzheimer's Disease",
    category: "Clinical",
    trialPercentage: "82%",
    inclusionExclusion: "Inclusion",
    fhirResource: "Observation",
    standardCode: "LOINC:72172-0",
    unstructured: "Clinical Dementia Rating: 1.0",
  },
  {
    term: "Amyloid PET positive",
    disorder: "Alzheimer's Disease",
    category: "Imaging/Biomarker",
    trialPercentage: "76%",
    inclusionExclusion: "Inclusion",
    fhirResource: "DiagnosticReport",
    standardCode: "SNOMED:432102000",
    unstructured: "Florbetapir PET shows significant amyloid deposition",
  },
  {
    term: "CSF Aβ42 < 600 pg/mL",
    disorder: "Alzheimer's Disease",
    category: "Lab/Pathology",
    trialPercentage: "71%",
    inclusionExclusion: "Inclusion",
    fhirResource: "Observation",
    standardCode: "LOINC:33747-0",
    unstructured: "CSF amyloid beta 42: 485 pg/mL",
  },
  {
    term: "APOE4 carrier status",
    disorder: "Alzheimer's Disease",
    category: "Genetic/Biomarker",
    trialPercentage: "65%",
    inclusionExclusion: "Inclusion",
    fhirResource: "Observation",
    standardCode: "LOINC:48018-6",
    unstructured: "APOE genotype: ε3/ε4 heterozygote",
  },
  {
    term: "Stable medications ≥4 weeks",
    disorder: "Alzheimer's Disease",
    category: "Treatment History",
    trialPercentage: "92%",
    inclusionExclusion: "Inclusion",
    fhirResource: "MedicationStatement",
    standardCode: "SNOMED:182840001",
    unstructured: "Patient on stable donepezil 10mg daily x 8 weeks",
  },
  {
    term: "MRI compatible",
    disorder: "Alzheimer's Disease",
    category: "Clinical",
    trialPercentage: "89%",
    inclusionExclusion: "Inclusion",
    fhirResource: "Condition",
    standardCode: "SNOMED:182840001",
    unstructured: "No contraindications to MRI scanning",
  },
  // Parkinson's Disease
  {
    term: "Hoehn & Yahr stage 1-3",
    disorder: "Parkinson's Disease",
    category: "Clinical",
    trialPercentage: "91%",
    inclusionExclusion: "Inclusion",
    fhirResource: "Observation",
    standardCode: "SNOMED:373873005",
    unstructured: "Hoehn and Yahr stage 2.5",
  },
  {
    term: "UPDRS Part III ≥ 20",
    disorder: "Parkinson's Disease",
    category: "Clinical",
    trialPercentage: "85%",
    inclusionExclusion: "Inclusion",
    fhirResource: "Observation",
    standardCode: "LOINC:72684-4",
    unstructured: "UPDRS motor score: 28 points",
  },
  {
    term: "DaTscan abnormal",
    disorder: "Parkinson's Disease",
    category: "Imaging",
    trialPercentage: "78%",
    inclusionExclusion: "Inclusion",
    fhirResource: "DiagnosticReport",
    standardCode: "SNOMED:432102000",
    unstructured: "DaTscan shows reduced striatal uptake",
  },
  {
    term: "Levodopa responsive",
    disorder: "Parkinson's Disease",
    category: "Treatment History",
    trialPercentage: "88%",
    inclusionExclusion: "Inclusion",
    fhirResource: "MedicationStatement",
    standardCode: "SNOMED:387467008",
    unstructured: "Good response to carbidopa/levodopa 25/100mg TID",
  },
  // Epilepsy
  {
    term: "Seizure frequency ≥2/month",
    disorder: "Epilepsy",
    category: "Clinical",
    trialPercentage: "93%",
    inclusionExclusion: "Inclusion",
    fhirResource: "Observation",
    standardCode: "SNOMED:84757009",
    unstructured: "Patient reports 4-6 seizures per month",
  },
  {
    term: "EEG abnormalities",
    disorder: "Epilepsy",
    category: "Clinical",
    trialPercentage: "87%",
    inclusionExclusion: "Inclusion",
    fhirResource: "DiagnosticReport",
    standardCode: "LOINC:11524-6",
    unstructured: "EEG shows left temporal spike activity",
  },
  {
    term: "Failed ≥2 AEDs",
    disorder: "Epilepsy",
    category: "Treatment History",
    trialPercentage: "81%",
    inclusionExclusion: "Inclusion",
    fhirResource: "MedicationStatement",
    standardCode: "SNOMED:182840001",
    unstructured: "Inadequate response to phenytoin and carbamazepine",
  },
  // Multiple Sclerosis
  {
    term: "EDSS score 0-6.5",
    disorder: "Multiple Sclerosis",
    category: "Clinical",
    trialPercentage: "89%",
    inclusionExclusion: "Inclusion",
    fhirResource: "Observation",
    standardCode: "LOINC:72133-2",
    unstructured: "Expanded Disability Status Scale: 3.5",
  },
  {
    term: "Relapsing-remitting MS",
    disorder: "Multiple Sclerosis",
    category: "Clinical",
    trialPercentage: "76%",
    inclusionExclusion: "Inclusion",
    fhirResource: "Condition",
    standardCode: "SNOMED:24700007",
    unstructured: "Diagnosis: Relapsing-remitting multiple sclerosis",
  },
  {
    term: "MRI gadolinium enhancing lesions",
    disorder: "Multiple Sclerosis",
    category: "Imaging",
    trialPercentage: "72%",
    inclusionExclusion: "Inclusion",
    fhirResource: "DiagnosticReport",
    standardCode: "SNOMED:432102000",
    unstructured: "Brain MRI shows 3 enhancing lesions",
  },
  // ALS
  {
    term: "ALSFRS-R score ≥20",
    disorder: "ALS",
    category: "Clinical",
    trialPercentage: "94%",
    inclusionExclusion: "Inclusion",
    fhirResource: "Observation",
    standardCode: "LOINC:72684-4",
    unstructured: "ALS Functional Rating Scale-Revised: 32",
  },
  {
    term: "Forced vital capacity ≥50%",
    disorder: "ALS",
    category: "Clinical",
    trialPercentage: "86%",
    inclusionExclusion: "Inclusion",
    fhirResource: "Observation",
    standardCode: "LOINC:19926-5",
    unstructured: "FVC: 68% of predicted value",
  },
  // Huntington's Disease
  {
    term: "CAG repeats ≥36",
    disorder: "Huntington's Disease",
    category: "Genetic",
    trialPercentage: "100%",
    inclusionExclusion: "Inclusion",
    fhirResource: "Observation",
    standardCode: "LOINC:48018-6",
    unstructured: "HTT gene: 42 CAG repeats",
  },
  {
    term: "UHDRS motor score ≥5",
    disorder: "Huntington's Disease",
    category: "Clinical",
    trialPercentage: "88%",
    inclusionExclusion: "Inclusion",
    fhirResource: "Observation",
    standardCode: "LOINC:72684-4",
    unstructured: "Unified Huntington's Disease Rating Scale motor: 12",
  },
];

export const oncologyData: EligibilityTerm[] = [
  // Lung Cancer
  {
    term: "Histologically confirmed NSCLC",
    cancerType: "Lung",
    category: "Clinical",
    trialPercentage: "98%",
    inclusionExclusion: "Inclusion",
    fhirResource: "Condition",
    standardCode: "SNOMED:254637007",
    unstructured: "Pathology: Non-small cell lung adenocarcinoma",
  },
  {
    term: "EGFR mutation positive",
    cancerType: "Lung",
    category: "Genetic/Biomarker",
    trialPercentage: "45%",
    inclusionExclusion: "Inclusion",
    fhirResource: "Observation",
    standardCode: "LOINC:48018-6",
    unstructured: "EGFR exon 19 deletion detected",
  },
  {
    term: "PD-L1 expression ≥50%",
    cancerType: "Lung",
    category: "Lab/Pathology",
    trialPercentage: "38%",
    inclusionExclusion: "Inclusion",
    fhirResource: "Observation",
    standardCode: "LOINC:85337-4",
    unstructured: "PD-L1 tumor proportion score: 65%",
  },
  {
    term: "Stage IIIB-IV disease",
    cancerType: "Lung",
    category: "Clinical",
    trialPercentage: "87%",
    inclusionExclusion: "Inclusion",
    fhirResource: "Observation",
    standardCode: "SNOMED:258215001",
    unstructured: "TNM staging: T3N2M1a (Stage IV)",
  },
  {
    term: "ECOG performance status 0-1",
    cancerType: "Lung",
    category: "Functional",
    trialPercentage: "92%",
    inclusionExclusion: "Inclusion",
    fhirResource: "Observation",
    standardCode: "LOINC:89247-1",
    unstructured: "ECOG performance status: 1",
  },
  {
    term: "Measurable disease by RECIST",
    cancerType: "Lung",
    category: "Imaging",
    trialPercentage: "89%",
    inclusionExclusion: "Inclusion",
    fhirResource: "DiagnosticReport",
    standardCode: "SNOMED:432102000",
    unstructured: "CT chest: 3.2cm right upper lobe mass",
  },
  // Breast Cancer
  {
    term: "HER2 positive (3+ or FISH+)",
    cancerType: "Breast",
    category: "Lab/Pathology",
    trialPercentage: "67%",
    inclusionExclusion: "Inclusion",
    fhirResource: "Observation",
    standardCode: "LOINC:48676-1",
    unstructured: "HER2/neu: 3+ by IHC, amplified by FISH",
  },
  {
    term: "Hormone receptor status",
    cancerType: "Breast",
    category: "Lab/Pathology",
    trialPercentage: "94%",
    inclusionExclusion: "Inclusion",
    fhirResource: "Observation",
    standardCode: "LOINC:16112-5",
    unstructured: "ER positive (85%), PR positive (70%)",
  },
  {
    term: "Metastatic or locally advanced",
    cancerType: "Breast",
    category: "Clinical",
    trialPercentage: "78%",
    inclusionExclusion: "Inclusion",
    fhirResource: "Condition",
    standardCode: "SNOMED:94391008",
    unstructured: "Metastatic breast cancer with liver involvement",
  },
  {
    term: "BRCA1/2 mutation status",
    cancerType: "Breast",
    category: "Genetic/Biomarker",
    trialPercentage: "42%",
    inclusionExclusion: "Inclusion",
    fhirResource: "Observation",
    standardCode: "LOINC:48018-6",
    unstructured: "BRCA1 pathogenic variant c.5266dupC",
  },
  {
    term: "Prior anthracycline exposure",
    cancerType: "Breast",
    category: "Treatment History",
    trialPercentage: "56%",
    inclusionExclusion: "Inclusion",
    fhirResource: "MedicationStatement",
    standardCode: "SNOMED:387467008",
    unstructured: "Previous doxorubicin-based chemotherapy",
  },
  // Blood Cancer
  {
    term: "CD20 positive B-cell lymphoma",
    cancerType: "Blood",
    category: "Lab/Pathology",
    trialPercentage: "89%",
    inclusionExclusion: "Inclusion",
    fhirResource: "Observation",
    standardCode: "LOINC:33747-0",
    unstructured: "Flow cytometry: CD20+ B-cell population",
  },
  {
    term: "Relapsed/refractory disease",
    cancerType: "Blood",
    category: "Clinical",
    trialPercentage: "76%",
    inclusionExclusion: "Inclusion",
    fhirResource: "Condition",
    standardCode: "SNOMED:263851003",
    unstructured: "Progressive disease after 2 prior therapies",
  },
  {
    term: "Bone marrow blast count",
    cancerType: "Blood",
    category: "Lab/Pathology",
    trialPercentage: "83%",
    inclusionExclusion: "Inclusion",
    fhirResource: "Observation",
    standardCode: "LOINC:26446-4",
    unstructured: "Bone marrow biopsy: 65% blasts",
  },
  {
    term: "Cytogenetic abnormalities",
    cancerType: "Blood",
    category: "Genetic/Biomarker",
    trialPercentage: "71%",
    inclusionExclusion: "Inclusion",
    fhirResource: "Observation",
    standardCode: "LOINC:48018-6",
    unstructured: "Karyotype: t(14;18)(q32;q21)",
  },
  // Skin Cancer
  {
    term: "Unresectable or metastatic melanoma",
    cancerType: "Skin",
    category: "Clinical",
    trialPercentage: "91%",
    inclusionExclusion: "Inclusion",
    fhirResource: "Condition",
    standardCode: "SNOMED:372244006",
    unstructured: "Stage IV melanoma with lung metastases",
  },
  {
    term: "BRAF V600E/K mutation",
    cancerType: "Skin",
    category: "Genetic/Biomarker",
    trialPercentage: "58%",
    inclusionExclusion: "Inclusion",
    fhirResource: "Observation",
    standardCode: "LOINC:48018-6",
    unstructured: "BRAF V600E mutation detected",
  },
  {
    term: "LDH level",
    cancerType: "Skin",
    category: "Lab",
    trialPercentage: "74%",
    inclusionExclusion: "Inclusion",
    fhirResource: "Observation",
    standardCode: "LOINC:2532-0",
    unstructured: "Serum LDH: 245 U/L (normal range)",
  },
  {
    term: "Brain metastases status",
    cancerType: "Skin",
    category: "Imaging",
    trialPercentage: "68%",
    inclusionExclusion: "Exclusion",
    fhirResource: "DiagnosticReport",
    standardCode: "SNOMED:432102000",
    unstructured: "Brain MRI: No evidence of metastatic disease",
  },
];

// Trial mappings for each condition
export const trialMappings = {
  neurology: {
    "Alzheimer's Disease": [
      "CLARITY-AD",
      "EMERGE",
      "ENGAGE",
      "EXPEDITION3",
      "GRADUATE I",
      "GRADUATE II",
      "TRAILBLAZER-ALZ",
      "AMARANTH",
      "TAURIEL",
    ],
    "Parkinson's Disease": [
      "SPARK",
      "STEADY-PD III",
      "SURE-PD3",
      "PROUD",
      "PASADENA",
      "BIIB054-201",
      "PRASINEZUMAB",
      "CINPANEMAB",
    ],
    Epilepsy: [
      "ELEVATE",
      "NAUTILUS",
      "YKP3089-E01",
      "REALIZE",
      "EPIMAG",
      "FREEDOM",
      "RESTORE-1",
      "NAUTILUS",
    ],
    "Multiple Sclerosis": [
      "ASCLEPIOS I",
      "ASCLEPIOS II",
      "DECIDE",
      "OPERA I",
      "OPERA II",
      "LIBERTY",
      "OLYMPUS",
      "ORATORIO",
    ],
    ALS: [
      "CENTAUR",
      "PHOENIX",
      "HEALEY ALS",
      "VALOR",
      "FORTITUDE-ALS",
      "LIGHTHOUSE",
      "ATLAS",
      "COURAGE-ALS",
    ],
    "Huntington's Disease": [
      "GENERATION HD1",
      "PRECISION-HD1",
      "PRECISION-HD2",
      "SIGNAL",
      "PROOF-HD",
      "VIBRANT-HD",
      "KINECT-HD",
    ],
  },
  oncology: {
    Lung: [
      "KEYNOTE-189",
      "KEYNOTE-407",
      "IMpower150",
      "ADAURA",
      "FLAURA",
      "ALEX",
      "ALINA",
      "CROWN",
      "MARIPOSA",
    ],
    Breast: [
      "KATHERINE",
      "APHINITY",
      "CLEOPATRA",
      "EMILIA",
      "DESTINY-Breast01",
      "MONARCH 2",
      "MONARCH 3",
      "PALOMA-2",
      "PALOMA-3",
    ],
    Blood: [
      "ZUMA-1",
      "JULIET",
      "SCHOLAR-1",
      "TRANSCEND",
      "CARTITUDE-1",
      "KarMMa",
      "LEGEND-2",
      "CARTITUDE-2",
    ],
    Skin: [
      "KEYNOTE-006",
      "CheckMate 067",
      "COMBI-d",
      "COMBI-v",
      "COLUMBUS",
      "BEACON",
      "RELATIVITY-047",
      "DREAMseq",
    ],
  },
};
